Información del producto
- Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala Trifluoroacetate
- Ala-Ile Val-Val-Gly-Gly-Val-Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-Val-Asp-Glu-Ala-Phe-Phe-Val-Leu-Lys-Gln-His-His-Val-Glu-Tyr-Gly-Ser-Asp-His-Arg-Phe-Glu-Ala-Asp Trifluoroacetate
- Amyloid Beta-Protein (42-1) Trifluoroacetate
- Amyloid Beta-Protein (Human, 1-42) Trifluoroacetate
- Peptide With Reversed Sequence Of Amyloid Beta-Protein (Human, 1-42) Trifluoroacetate
- Aβ42-1
Reverse sequence of Aβ42, inactive control for the Aβ. Treating Aβ-peptides with 1,1,1,3,3,3-hexafluoroisopropanol (HFIP) is the standard method for disrupting amyloid fibrils and generating the Aβ monomers. Working with HFIP-treated Aβ-peptides has the advantage of getting more reproducible results whereas untreated Aβ-peptides may contain varying amounts and types of oligomeric structures.
Propiedades químicas
Consulta técnica sobre: 01-4107743 Amyloid β-Protein (42-1) (HFIP-treated)
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.